Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Long-Term Results of a Prospective Multinational Registry.

Background—The risks of sports participation for implantable cardioverter-defibrillator (ICD) patients are unknown. Methods and Results—Athletes with ICDs (age, 10–60 years) participating in organized (n=328) or high-risk (n=44) sports were recruited. Sports-related and clinical data were obtained by phone interview and medical records. Follow-up occurred every 6 months. ICD shock data and clinical outcomes were adjudicated by 2 electrophysiologists. Median age was 33 years (89 subjects <20 years of age); 33% were female. Sixty were competitive athletes (varsity/junior varsity/traveling team). A pre-ICD history of ventricular arrhythmia was present in 42%. Running, basketball, and soccer were the most common sports. Over a median 31-month (interquartile range, 21–46 months) follow-up, there were no occurrences of either primary end point—death or resuscitated arrest or arrhythmia- or shock-related injury—during sports. There were 49 shocks in 37 participants (10% of study population) during competition/pr...

[1]  M. Link,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology. , 2015, Journal of the American College of Cardiology.

[2]  Children ’ s Hospitals and Clinics of Minnesota , 2015 .

[3]  F. Lippman.  Miami Children's Hospital , 2014 .

[4]  S. Russell,et al.  Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. , 2013, Journal of the American College of Cardiology.

[5]  M. Link,et al.  Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Results of a Prospective, Multinational Registry , 2013, Circulation.

[6]  Wojciech Zareba,et al.  Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.

[7]  Hein Heidbuchel,et al.  Ventricular arrhythmias associated with long-term endurance sports: what is the evidence? , 2012, British Journal of Sports Medicine.

[8]  M. Barry,et al.  Shared decision making--pinnacle of patient-centered care. , 2012, The New England journal of medicine.

[9]  A. Zwinderman,et al.  Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  R. Duncan,et al.  Adolescents with Implantable Cardioverter Defibrillators: A Patient and Parent Perspective , 2012, Pacing and clinical electrophysiology : PACE.

[11]  A. Skanes,et al.  Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia. , 2011, Heart rhythm.

[12]  W. Maisel,et al.  34 – Guidelines for Managing Pacemaker and Implantable Defibrillator Advisories , 2011 .

[13]  P. Heidenreich,et al.  Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up: The ALTITUDE Survival Study , 2010, Circulation.

[14]  Vicki L Zeigler,et al.  Determining Psychosocial Research Priorities for Adolescents With Implantable Cardioverter Defibrillators Using Delphi Methodology , 2010, The Journal of cardiovascular nursing.

[15]  L. Salberg,et al.  Patient Advocacy: What Is Its Role? , 2009, Pacing and clinical electrophysiology : PACE.

[16]  Stephen L Moore,et al.  Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. , 2008, Journal of the American College of Cardiology.

[17]  J. Triedman,et al.  Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. , 2008, Journal of the American College of Cardiology.

[18]  A. Moss,et al.  Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. , 2007, Heart rhythm.

[19]  V. Shusterman,et al.  Implantable Cardioverter‐Defibrillator Shocks Increase T‐Wave Alternans , 2007, Journal of cardiovascular electrophysiology.

[20]  Angelo Auricchio,et al.  Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy , 2007 .

[21]  G. Breithardt,et al.  Age- and Training-Dependent Development of Arrhythmogenic Right Ventricular Cardiomyopathy in Heterozygous Plakoglobin-Deficient Mice , 2006, Circulation.

[22]  Pietro Delise,et al.  Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions Part II: Ventricular arrhythmias, channelopathies and implantable defibrillators , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[23]  D. Cannom,et al.  Safety of Sports Participation in Patients with Implantable Cardioverter Defibrillators: 
A Survey of Heart Rhythm Society Members , 2006, Journal of cardiovascular electrophysiology.

[24]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[25]  R. Bonow,et al.  36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes With Cardiovascular Abnormalities , 2005 .

[26]  M. Link,et al.  Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2003, Circulation.

[27]  Maurizio Schiavon,et al.  Does sports activity enhance the risk of sudden death in adolescents and young adults? , 2003, Journal of the American College of Cardiology.

[28]  L. Fananapazir,et al.  Efficacy of Implantable Cardioverter Defibrillator Therapy for Primary and Secondary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy , 2003, Pacing and clinical electrophysiology : PACE.

[29]  H. Heidbuchel,et al.  High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. , 2003, European heart journal.

[30]  S. Viskin.  Implantable Cardioverter Defibrillator in High‐Risk Long QT Syndrome Patients , 2003, Journal of cardiovascular electrophysiology.

[31]  Diwakar Jain,et al.  Emotional and Physical Precipitants of Ventricular Arrhythmia , 2002, Circulation.

[32]  J. Kluger,et al.  Ineffective ICD Therapy Due to Excessive Alcohol and Exercise , 2002, Pacing and clinical electrophysiology : PACE.

[33]  R. Ideker,et al.  Impact of Myocardial Ischemia and Reperfusion on Ventricular Defibrillation Patterns, Energy Requirements, and Detection of Recovery , 2002, Circulation.

[34]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[35]  A. Motamedi,et al.  Quality of Life Assessment in Elite Collegiate Athletes * , 2001, The American journal of sports medicine.

[36]  M. Link,et al.  Report of the NASPE Policy Conference on Arrhythmias and the Athlete , 2001, Journal of cardiovascular electrophysiology.

[37]  Y. Deychak,et al.  Electrophysiologic basis by which epinephrine facilitates defibrillation after prolonged episodes of ventricular fibrillation. , 2001, Annals of emergency medicine.

[38]  D. Wyse,et al.  Electrical Storm Presages Nonsudden Death: The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial , 2001, Circulation.

[39]  B. Maron,et al.  The paradox of exercise. , 2000, The New England journal of medicine.

[40]  J. Manson,et al.  Triggering of sudden death from cardiac causes by vigorous exertion. , 2000, The New England journal of medicine.

[41]  M. Link,et al.  Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[42]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[43]  C. Schuger,et al.  Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses. , 1999, Journal of the American College of Cardiology.

[44]  F O Mueller,et al.  Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. , 1996, JAMA.

[45]  H. Calkins,et al.  Effect of epinephrine on the efficacy of the internal cardioverter-defibrillator. , 1992, The American journal of cardiology.

[46]  O. Sejersted,et al.  Plasma potassium changes with high intensity exercise. , 1990, The Journal of physiology.